x

BIO-RAD LABORATORIES, INC. (NYSE:BIO)

Health Care/Life Sciences • Medical Equipment/Supplies
CIK 12208
Company

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Address
1000 Alfred Nobel Drive
Hercules, California 94547
Employees
8,030
Stock Info
Close
$344.25
Day Range
341.64 - 347.99
52 Week Range
261.59 - 499.27
Average volume
230.03K
Short Interest
503.41K (02/29/24)
% of Float Shorted
2.56%
Market Cap
$9.81B
Revenue
$2.67B
Net Income
-$637.32M
2020 Sales Growth
N/A
Rev. per Employee
$332.66K
P/E Ratio
N/A
EPS
-$21.50
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman, President & Chief Executive Officer
Norman D Schwartz
Non-Independent Director
Allison Schwartz
Director-Emeritus
Alice N Schwartz
Lead Independent Director
Gregory K Hinckley MBA, CPA
Independent Director
Jeffrey L Edwards
Independent Director
Melinda Litherland CPA
Independent Director
Arnold A Pinkston
SEC filings
DateFormEvent
5 Sep, 2024 4
4 Sep, 2024 4
4 Sep, 2024 4
4 Sep, 2024 4
4 Sep, 2024 4
4 Sep, 2024 4
4 Sep, 2024 144
28 Aug, 2024 4
28 Aug, 2024 4
28 Aug, 2024 4
28 Aug, 2024 4
27 Aug, 2024 144
20 Aug, 2024 8-K
2 Aug, 2024 10-Q
1 Aug, 2024 8-K
29 Jul, 2024 4
17 Jun, 2024 3
14 Jun, 2024 4
13 Jun, 2024 144
9 May, 2024 SD
8 May, 2024 3
8 May, 2024 S-8
8 May, 2024 10-Q
7 May, 2024 8-K
1 May, 2024 4
30 Apr, 2024 4
29 Apr, 2024 3
29 Apr, 2024 4
29 Apr, 2024 4
26 Apr, 2024 8-K
22 Apr, 2024 SC 13G
17 Apr, 2024 3
10 Apr, 2024 8-K
27 Mar, 2024 DEF 14A
27 Mar, 2024 ARS
20 Mar, 2024 8-K
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
11 Mar, 2024 SC 13G/A
29 Feb, 2024 4
28 Feb, 2024 144
28 Feb, 2024 4
27 Feb, 2024 144
27 Feb, 2024 144
21 Feb, 2024 8-K
16 Feb, 2024 10-K
15 Feb, 2024 8-K
14 Feb, 2024 8-K CEO Change
13 Feb, 2024 SC 13G/A
29 Jan, 2024 SC 13G/A
19 Dec, 2023 4
14 Dec, 2023 4
12 Dec, 2023 4
12 Dec, 2023 144
8 Dec, 2023 4
7 Dec, 2023 4
7 Dec, 2023 4
7 Dec, 2023 8-K
28 Nov, 2023 4
28 Nov, 2023 144
28 Nov, 2023 144
2 Nov, 2023 4
27 Oct, 2023 10-Q
26 Oct, 2023 8-K
23 Oct, 2023 4
17 Oct, 2023 8-K
27 Sep, 2023 3
14 Sep, 2023 3
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
6 Sep, 2023 4
31 Aug, 2023 4
30 Aug, 2023 144
28 Aug, 2023 4
25 Aug, 2023 8-K
23 Aug, 2023 144
23 Aug, 2023 4
4 Aug, 2023 10-Q
3 Aug, 2023 8-K
20 Jul, 2023 8-K
16 Jun, 2023 4
15 Jun, 2023 144
7 Jun, 2023 4
6 Jun, 2023 144
5 Jun, 2023 8-K
24 May, 2023 SD
5 May, 2023 10-Q
4 May, 2023 8-K
4 May, 2023 3
1 May, 2023 4
1 May, 2023 8-K
1 May, 2023 4
11 Apr, 2023 4
29 Mar, 2023 ARS
29 Mar, 2023 DEF 14A
8 Mar, 2023 4
23 Feb, 2023 8-K
17 Feb, 2023 10-K
16 Feb, 2023 8-K
14 Feb, 2023 4
9 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
1 Feb, 2023 SC 13G/A
10 Jan, 2023 8-K
19 Dec, 2022 4
16 Dec, 2022 UPLOAD
14 Dec, 2022 CORRESP
7 Dec, 2022 4
2 Dec, 2022 UPLOAD
1 Dec, 2022 4
28 Nov, 2022 4
21 Nov, 2022 4
14 Nov, 2022 4
8 Nov, 2022 8-K
28 Oct, 2022 10-Q
27 Oct, 2022 8-K
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
7 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
6 Sep, 2022 4
29 Aug, 2022 4
11 Aug, 2022 CORRESP
8 Aug, 2022 4
29 Jul, 2022 UPLOAD
29 Jul, 2022 10-Q
28 Jul, 2022 8-K
25 May, 2022 SD
18 May, 2022 8-K
11 May, 2022 CORRESP
6 May, 2022 3
2 May, 2022 4
2 May, 2022 4
29 Apr, 2022 10-Q
28 Apr, 2022 8-K
28 Apr, 2022 3
27 Apr, 2022 UPLOAD
20 Apr, 2022 8-K
11 Apr, 2022 4
11 Apr, 2022 SC 13D/A
30 Mar, 2022 DEF 14A
28 Mar, 2022 8-K
2 Mar, 2022 8-K
25 Feb, 2022 424B2
25 Feb, 2022 8-K
24 Feb, 2022 FWP
23 Feb, 2022 424B5
15 Feb, 2022 S-3ASR
11 Feb, 2022 10-K
10 Feb, 2022 8-K
9 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
1 Feb, 2022 SC 13G/A
7 Jan, 2022 3
17 Dec, 2021 4
29 Nov, 2021 8-K
23 Nov, 2021 4
23 Nov, 2021 4
23 Nov, 2021 4
18 Nov, 2021 8-K
15 Nov, 2021 4
29 Oct, 2021 10-Q
28 Oct, 2021 8-K
4 Oct, 2021 8-K
9 Sep, 2021 4
9 Sep, 2021 4
9 Sep, 2021 4
9 Sep, 2021 4
8 Sep, 2021 4
8 Sep, 2021 4
8 Sep, 2021 4
8 Sep, 2021 4
8 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
3 Sep, 2021 4
27 Aug, 2021 4
10 Aug, 2021 4
5 Aug, 2021 4
5 Aug, 2021 4
30 Jul, 2021 10-Q
29 Jul, 2021 8-K
17 May, 2021 SD
3 May, 2021 4
30 Apr, 2021 10-Q
30 Apr, 2021 4
29 Apr, 2021 8-K
9 Apr, 2021 4
31 Mar, 2021 DEF 14A
22 Feb, 2021 4
16 Feb, 2021 10-K
11 Feb, 2021 8-K
10 Feb, 2021 SC 13G/A
8 Feb, 2021 SC 13G
4 Feb, 2021 8-K
29 Jan, 2021 SC 13G/A
22 Jan, 2021 UPLOAD
5 Jan, 2021 CORRESP
29 Dec, 2020 UPLOAD
Last update:2024-03-12 12:02:28.255432
BIO-RAD LABORATORIES, INC. by TradingView

Sign Up to Subscribe